Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 December 2017 to Question 119906, what steps he took to ascertain why the market price of amlodipine 5mg tablets was above the reimbursement price listed in the Drug Tariff prior to granting a concessionary price.

Before granting a concessionary price we contact suppliers to ascertain that the product was not available at or below the reimbursement price listed in the Drug Tariff. While a specific assessment was not made as to why this particular product was not available at or below the reimbursement price listed in the Drug Tariff, we are aware of a number of reasons for the pressure in the supply chain generally.